Cheapest Legal GLP-1 Online (2026): 50-State Compounded Sema $99/mo
Cheapest legal compounded GLP-1 online in 2026: $99/mo semaglutide, $125/mo tirzepatide on the annual plan, 503A pharmacies, 50 states, all-in prices compared.
Quick answer
The cheapest legal GLP-1 online in 2026 with 50-state shipping is Trimi Health, at $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan, a 12-month commitment billed once yearly. Both medications are dispensed by 503A community sterile compounding pharmacies (BelieveRx and GreenwichRx) and prescribed by state-licensed clinicians. Pricing is all-inclusive, medication, consultations, shipping, and support, with no first-month teaser rate that escalates later; the annual plan is backed by a 6-month money-back policy with eligibility conditions, and month-to-month billing is $175 and $235.
- Cheapest: $99/mo (sema) and $125/mo (tirz) on annual billing, flat across all dose levels.
- Legal: Compounded per individual prescription under federal statute by 503A sterile compounding pharmacies.
- Verifiable pharmacy: BelieveRx holds Texas State Board of Pharmacy license #35264, which anyone can look up on the board's public license search.
- 50 states: 50-state clinician network covers all US patients (eligibility confirmed at medical evaluation).
- No bait pricing: $99/$125 is the steady-state rate, not a month-one teaser.
More on GLP-1 Cost & Provider Selection
Trial evidence. In the STEP 1 trial, adults taking branded semaglutide 2.4 mg lost a mean 14.9% of body weight at 68 weeks versus 2.4% on placebo. In SURMOUNT-1, adults taking branded tirzepatide 15 mg lost a mean 20.9% at 72 weeks versus 3.1% on placebo. These are results for the FDA-approved branded drugs; compounded preparations have not been separately trialed, and individual results vary.
What "cheapest legal GLP-1" actually means
"Cheap" without "legal" is dangerous; "legal" without "cheap" is the brand-name market. The intersection, a legitimate, regulated, cash-affordable GLP-1, exists in the compounded telehealth tier, but only at providers that meet four objective markers.
The legitimacy markers
- State-board-licensed sterile compounding pharmacy. Federal compounding law splits pharmacies into two tiers: 503A (state-board-overseen, prepared per individual prescription, regulated under USP <797> sterile compounding standards) and 503B (FDA-overseen outsourcing facilities operating under cGMP standards). 503A is the per-prescription tier the vast majority of legitimate compounded GLP-1 in the US comes from. Trimi works with two 503A sterile compounding pharmacies: BelieveRx (Texas State Board license #35264, Class: Community Sterile Compounding, Sterile-Risk Level Med, no prior disciplinary orders, PIC: F.B. Bucky Payne) and GreenwichRx (also a 503A sterile compounding pharmacy).
- State-licensed clinicians with named credentials. The prescribing clinician must hold an active license in the patient's state. Marketplace platforms that connect patients to "any available prescriber" without name + credential verification are a red flag.
- Required medical evaluation prior to prescribing. Click-to-purchase platforms that skip clinical evaluation are operating outside the standard of care. Trimi requires a 10–15-minute health questionnaire and clinician review before any prescription is issued.
- Third-party verification. LegitScript Healthcare Merchant Certification verifies regulatory compliance, transparent business practices, and patient-safety controls. NABP Safe Pharmacy is the analogous mark for the pharmacy side. Look for the explicit certification, not just a logo.
Pharmacy compliance: addressing the public regulatory question
A regulatory critique that recurs in r/TirzepatideRX and r/compoundedtirzepatide threads about Trimi states that VialsRx, the pharmacy now operating as BelieveRx, "doesn't have the required 'Compounding Sterile-Risk Level High' classification needed to make GLP-1 meds in TX." The Texas State Board record (license #35264, public lookup) confirms BelieveRx holds Sterile-Risk Level Low and Med classifications, not High. Per USP <797>, "High-Risk Level" sterile compounding is required only when compounding from non-sterile starting components, typical GLP-1 sterile compounding from sterile semaglutide or tirzepatide API qualifies as Medium-Risk, which BelieveRx is licensed for. The license is active through 02/29/2028 with no prior disciplinary orders and a Pharmacist-in-Charge (F.B. Bucky Payne, license #21387) registered since 1975.
All-in pricing: compounded semaglutide at a maintenance dose, nine telehealth providers
Every figure was read off the provider’s own public pricing page on 4 September 2026 (Eden: 2 August 2026, because its page refused access on 4 September). All-in includes any membership or programme fee a provider requires to receive medication. Verify current pricing on each provider’s site before deciding. Tirzepatide is compared in the cheapest tirzepatide providers ranking.
| Provider | Entry price | All-in at maintenance | Est. annual cost | Contract |
|---|---|---|---|---|
| Trimi Health | $99/mo annual plan | $99/mo annual plan | $1,188 | 12-month annual plan ($175/mo month to month) |
| Found | $169/mo | $169/mo | $2,028 | 12-month prepaid |
| Henry Meds | $179/mo | $179/mo | $2,148 | Multi-month plans |
| Mochi Health | $79 membership + medication | $178+/mo all-in (medication price varies by dose) | $2,136+ | Membership |
| TrimRx | $179/mo | $179/mo | $2,148 | Varies |
| Eden | $99 + $99 membership | $198/mo all-in | $2,376 | Membership |
| Zealthy | $151 + $135 membership | $286/mo all-in | $3,432 | Membership |
| Lemonaid Health | $249 + $49 membership | $298/mo all-in | $3,576 | 3-month plan ($299/mo monthly) |
| Noom Med | $249/mo | $249-299/mo | $2,988-$3,588 | Quarterly billing |
Over a 12-month course at a maintenance dose, Trimi’s annual plan totals $1,188, against $2,028 to $3,588 for the other providers in this table. Hims, Ro, WeightWatchers and Calibrate no longer offer compounded GLP-1s to new patients and now sell FDA-approved brand medication, so they are not in a compounded all-in comparison.
Trimi billing plans explained (no hidden fine print)
The $99/mo and $125/mo headline rates above are the lowest published prices Trimi offers, both on the annual prepay plan. Trimi also offers shorter-commitment plans at progressively higher monthly rates. The full tier structure is published openly for both medications and on every plan tier the medication itself, consultations, shipping, and patient support are bundled (no add-on consultation fees, no shipping fees, no titration markups). For a provider-by-provider view of who does and does not charge these extras, see the cheapest GLP-1 without membership fees comparison.
Compounded semaglutide tiers
| Plan | Effective monthly | Charged | Commitment |
|---|---|---|---|
| Monthly | $175 | $175 each month | none |
| Quarterly | $145 | $435 every 3 months | 3 months |
| Bi-Annual | $120 | $720 every 6 months | 6 months |
| Annual (best value) | $99 | $1,188 billed once yearly | 12 months |
Compounded tirzepatide tiers
| Plan | Effective monthly | Charged | Commitment |
|---|---|---|---|
| Monthly | $235 | $235 each month | none |
| Quarterly | $199 | $597 every 3 months | 3 months |
| 6 Months | $175 | $1,050 every 6 months | 6 months |
| Annual (best value) | $125 | $1,500 billed once yearly | 12 months |
In the nine-provider comparison above, re-checked 4 September 2026, Trimi’s annual plan was the lowest all-in monthly cost for compounded semaglutide at a maintenance dose. On month-to-month billing, Trimi’s $175 semaglutide rate sits close to the other providers’ all-in maintenance rates, and the $235 tirzepatide rate is compared in the tirzepatide ranking. Brand-name self-pay pricing is covered separately in our brand cost guides. Cancellation and refund terms are published per tier before checkout, and patients always keep any medication already shipped. For how Trimi's flat tirzepatide rate compares with every other compounded-tirzepatide program at maintenance dose, see the cheapest tirzepatide providers ranking.
Compounded versus brand-name GLP-1: what differs
Wegovy, Ozempic, Mounjaro and Zepbound are FDA-approved finished drugs, reviewed by FDA for safety and effectiveness before marketing and made by Novo Nordisk and Eli Lilly. Compounded semaglutide and tirzepatide are a different regulatory category: a licensed prescriber writes a prescription for one patient, and a state-licensed 503A pharmacy prepares it for that patient. Compounded preparations are not FDA-approved as drugs, and FDA does not review them for safety, effectiveness or quality before marketing.
Since FDA declared the semaglutide and tirzepatide shortages resolved, compounding is limited to that patient-specific pathway: where federal limits on copies of commercially available drugs apply, the prescriber must determine and document why a compounded preparation is appropriate for the individual patient. That is why a named, state-licensed 503A pharmacy and a required clinical evaluation are the trust markers to check.
50-state coverage explained
Compounded GLP-1 prescribing is regulated state-by-state. Three regulatory layers determine whether a patient in a given state can receive a compounded GLP-1 prescription:
- Provider state license: The prescribing clinician must hold an active medical license in the patient's billing state. Trimi's 50-state clinician network is operated through Arora Health (clinical-infrastructure partner), whose providers hold active medical licenses across all 50 states.
- Pharmacy non-resident permit: The dispensing pharmacy must hold a non-resident permit in the patient's state. Trimi's 503A sterile compounding partner pharmacies, BelieveRx and GreenwichRx, maintain the necessary state-by-state permits.
- Telehealth consent rules: A handful of states require specific patient-consent language for telehealth prescribing. Trimi's intake flow includes the required state-specific disclosures automatically.
Payment is taken at checkout, before provider review. If the provider determines treatment is not appropriate, the order is refunded in full under the refund policy.
State-specific coverage detail and per-state legality framing for every US state is published at /state/[your-state]. Example state pages: California, Texas, Florida, New York, Pennsylvania, Illinois. All 50 state landing pages are published; substitute your state's slug.
How Trimi compares head-to-head with each major competitor
Cluster pages with full feature-by-feature comparison detail:
- • Trimi vs Hims (semaglutide), Hims now sells FDA-approved brand medication to new patients; Trimi is cash-pay compounded at $99/mo on the annual plan
- • Trimi vs Ro Body, Ro focuses on brand-name medication and insurance coverage; Trimi is cash-pay compounded
- • Trimi vs Found, Trimi $99/mo on the annual plan vs Found $169/mo on a 12-month prepaid plan (re-checked 4 September 2026)
- • Trimi vs Mochi Health, flat pricing vs Mochi’s $79 membership plus dose-dependent medication charges
- • Trimi vs Henry Meds, Trimi $99/mo on the annual plan vs Henry Meds $179/mo at maintenance (re-checked 4 September 2026)
- • Trimi vs TrimRx, separate, unaffiliated companies despite confusingly similar names
What real Trimi customers say
Verbatim public reviews from Facebook and Reddit. Quotes preserve original phrasing and link to source for verification.
“Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.”
Same-day delivery experience
“Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!”
Down 12.5 lbs in 2 months
“21 lbs down in 6 weeks! So happy I started with you guys!”
21 lbs lost in 6 weeks
“Just recieved my order today. I placed order Monday afternoon and arrived this afternoon. Everything packaged great, clear instructions to follow. The customer service was excellent. I have tried other companies, but this is the most affordable by far. I am almost at my goal weight.”
Next-day arrival; most affordable tried; near goal weight
“It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.”
4-day delivery; 3 vials for first 3 months; price + convenience verdict positive
Frequently Asked Questions
What's the cheapest legal GLP-1 online in 2026?
In a comparison of nine licensed compounded-GLP-1 telehealth providers re-checked on 4 September 2026, Trimi Health had the lowest all-in monthly cost for compounded semaglutide at a maintenance dose: $99/month on the annual plan, a 12-month commitment billed $1,188 once yearly. Compounded tirzepatide is $125/month on the annual plan ($1,500 once yearly), and month-to-month billing is $175 and $235. Every plan includes medication, provider access, shipping and support. Both medications are dispensed by 503A community sterile compounding pharmacies, BelieveRx (Texas State Board of Pharmacy license #35264) and GreenwichRx, and prescribed by state-licensed clinicians. Trimi serves all 50 US states.
Is compounded GLP-1 FDA-approved?
Compounded medications are not FDA-approved as drugs. They are prepared per individual prescription by a licensed pharmacy under federal compounding statutes. Compounded semaglutide and tirzepatide are legally prescribed on the patient-specific pathway, where a clinician determines and documents why a compounded preparation is appropriate for the individual patient. 503A community sterile compounding pharmacies operate under state board of pharmacy oversight and USP <797> sterile compounding standards. The 503A tier is the per-prescription compounding tier; the higher 503B outsourcing-facility tier is FDA-overseen with cGMP standards but is not the tier Trimi's partner pharmacies operate under.
How is compounded GLP-1 different from brand-name GLP-1?
They are different regulatory categories. Wegovy, Ozempic, Mounjaro and Zepbound are FDA-approved finished drugs made by Novo Nordisk and Eli Lilly. Compounded semaglutide and tirzepatide are prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs; FDA does not review compounded drugs for safety, effectiveness or quality before marketing, and a prescriber must document why a compounded preparation is appropriate for the individual patient where federal limits apply. Brand-name self-pay prices are covered in our brand cost guides.
Why is Trimi cheaper than competitors?
Three structural reasons. First, flat all-inclusive pricing (medication, clinician, shipping, and support are bundled into the monthly price, no separate consultation fees, dispensing fees, or shipping fees). Second, no first-month bait pricing, many competitors advertise a $79-$99 introductory rate that escalates to $149-$299 from month two; Trimi's $99/$125 is the steady-state rate, not a promotional teaser. Third, 503A sterile compounding pharmacy partnerships at scale (BelieveRx, Texas State Board license #35264, GreenwichRx, also 503A sterile compounding) drive dispensing-cost economics that smaller telehealth platforms can't match.
Can I buy GLP-1 online in any US state?
Yes, Trimi serves patients in all 50 US states. The 50-state clinician network is operated through Arora Health, Trimi's clinical-infrastructure partner. Its providers hold state medical licenses across all 50 states. Compounded GLP-1 prescribing is regulated state-by-state, provider state licenses, pharmacy non-resident permits, and patient telehealth consent rules vary, and the licensure is held by the individual Arora clinicians who hold state-specific medical licenses, not by Trimi as a corporate entity. Ineligible patients (rare, typically driven by a specific state-board rule on a contraindication) are screened out at the medical evaluation step.
Is the cheapest GLP-1 always the safest?
No, and patients should avoid evaluating GLP-1 providers on price alone. The four legitimacy markers to look for are: (1) a 503A sterile compounding pharmacy partner (state-board-licensed, USP <797>-compliant), (2) state-licensed clinicians with named credentials, (3) a required medical evaluation prior to prescribing, never click-to-purchase, and (4) third-party certification you can check on the certifier's own site, not just a logo. Check every provider, including Trimi, against all four; not every cheap-pricing competitor meets them.
What's included in Trimi's $99/month?
Compounded semaglutide medication (30-day supply, all dose levels, no titration price increases), licensed clinician oversight including initial evaluation and ongoing check-ins, 24/7 messaging support, dose adjustments as clinically appropriate, free overnight cold-chain shipping once compounded, with tracking, syringes and alcohol swabs, and access to educational resources. There are no enrollment, membership or shipping fees. The $99 rate is the annual plan, a 12-month commitment billed $1,188 once yearly and backed by a 6-month money-back policy with eligibility conditions; month-to-month billing is $175.
How does Trimi compare to LillyDirect for cheapest legal access?
LillyDirect is Eli Lilly's direct-to-patient pharmacy for FDA-approved brand-name Zepbound, with self-pay prices published on Lilly's site and explained in our LillyDirect Zepbound pricing guide. Trimi provides compounded tirzepatide, a different regulatory category: it is prepared per individual prescription by a state-licensed 503A pharmacy and is not FDA-approved as a drug. Because they are different products, the choice is about which product you and your clinician consider appropriate, not price alone.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002 (STEP 1 trial).
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216 (SURMOUNT-1 trial).
- FDA. Compounding and the FDA: Questions and Answers.
- FDA. Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide), 2025.
- LegitScript. Healthcare Merchant Certification standards.
- Competitor pricing read from each provider's public pricing page on 4 September 2026 (Eden: 2 August 2026).
Medical Disclaimer: This content is for informational purposes only and is not medical advice, consult a licensed clinician before starting, stopping, or switching GLP-1 therapy. Compounded medications are prepared per individual prescription and are not FDA-approved as drugs. GLP-1 medications carry risks including nausea, pancreatitis, gallbladder disease, kidney injury, and a boxed warning for thyroid C-cell tumors. Competitor pricing reflects published rates as of 4 September 2026 and Trimi pricing is current as of 2026-09-28; verify current pricing on each provider's site. This comparison was authored by Trimi Health, which competes in this market, we have made every effort to represent competitor pricing accurately as of the date above.
Ready to start with the #1 lowest-cost legal GLP-1 provider?
Provider-guided compounded GLP-1 care with transparent flat pricing, compounded semaglutide as low as $99/mo or tirzepatide as low as $125/mo on the annual plan, all-inclusive (medication, US-licensed clinician via the Arora Health 50-state network, dose changes, refills, and free overnight shipping once compounded), backed by a 6-month money-back policy.